93
Views
9
CrossRef citations to date
0
Altmetric
REVIEW

Sentinel lymph node biopsy in the management of conjunctival melanoma: current insights

, , &
Pages 1297-1302 | Published online: 23 Jul 2019

References

  • Mor JM, Heindl LM. Systemic BRAF/MEK inhibitors as a potential treatment option in metastatic conjunctival melanoma. Ocul Oncol Pathol. 2017;3:133–141. doi:10.1159/000452473
  • Triay E, Bergman L, Nilsson B, All-Ericsson C, Seregard S. Time trends in the incidence of conjunctival melanoma in Sweden. Br J Ophthalmol. 2009;93:1524–1528. doi:10.1136/bjo.2009.157933
  • Norregaard JC, Gerner N, Jensen OA, Prause JU. Malignant melanoma of the conjunctiva: occurrence and survival following surgery and radiotherapy in a Danish population. Graefes Arch Clin Exp Ophthalmol. 1996;234:569–572.
  • Shields JA, Shields CL, De Potter P. Surgical management of conjunctival tumors. The 1994 Lynn B McMahan lecture. Arch Ophthalmol. 1997;115:808–815. doi:10.1001/archopht.1997.01100150810025
  • Heindl LM, Koch KR, Schlaak M, Mauch C, Cursiefen C. [Adjuvant therapy and interdisciplinary follow-up care of conjunctival melanoma]. Ophthalmologe. 2015;112:907–911.
  • Herold TR, Hintschich C. Interferon α for the treatment of melanocytic conjunctival lesions. Graefes Arch Clin Exp Ophthalmol. 2009;248:111–115. doi:10.1007/s00417-009-1189-0
  • Russell HC, Chadha V, Lockington D, Kemp EG. Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: a 10-year review of treatment outcomes and complications. Br J Ophthalmol. 2010;94:1316–1321.
  • Westekemper H, Meller D, Darawsha R, et al. Operative therapy and irradiation of conjunctival melanoma (in German). Ophthalmologe. 2015;112:899–906. doi:10.1007/s00347-015-0147-y
  • Glossmann JP, Skoetz N, Starbatty B, et al. [Conjunctival melanoma: standard operating procedures in diagnosis, treatment and follow-up care]. Ophthalmologe. 2018;115:489–498. doi:10.1007/s00347-018-0664-6
  • Shields CL, Shields JA, Gündüz K, et al. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol. 2000;118:1497–1507.
  • Esmaeli B, Wang X, Youssef A, Gershenwald JE. Patterns of regional and distant metastasis in patients with conjunctival melanoma: experience at a cancer center over four decades. Ophthalmology. 2001;108:2101–2105. doi:10.1016/S0161-6420(01)00782-5
  • Schlereth SL, Iden S, Mescher M, et al. a novel model of metastatic conjunctival melanoma in immune-competent mice. Invest Ophthalmol Vis Sci. 2015;56:5965–5973. doi:10.1167/iovs.15-17290
  • Refaian N, Schlereth SL, Koch KR, et al. Comparing the Hem- and lymphangiogenic profile of conjunctival and uveal melanoma cell lines. Invest Ophthalmol Vis Sci. 2015;56:5691–5697. doi:10.1167/iovs.15-16829
  • Werschnik C, Lommatzsch PK. Long-term follow-up of patients with conjunctival melanoma. Am J Clin Oncol. 2002;25:248–255.
  • Flaherty KT, Infante JR, Daud A, et al. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. N Engl J Med. 2012;367:1694–1703. doi:10.1056/NEJMoa1210093
  • Hodi FS, O’Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363:711–723. doi:10.1056/NEJMoa1011205
  • Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376:2211–2222. doi:10.1056/NEJMoa1613210
  • Pfeiffer ML, Ozgur OK, Myers JN, et al. Sentinel lymph node biopsy for ocular adnexal melanoma. Acta Ophthalmol. 2017;95:e323–e328. doi:10.1111/aos.13252
  • Heindl LM, Hofmann-Rummelt C, Adler W, et al. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva. Ophthalmology. 2011;118:2351–2360. doi:10.1016/j.ophtha.2011.05.025
  • Heindl LM, Hofmann-Rummelt C, Adler W, et al. Tumor-associated lymphangiogenesis in the development of conjunctival melanoma. Invest Ophthalmol Vis Sci. 2011;52:7074–7083. doi:10.1167/iovs.11-7902
  • Ho VH, Ross MI, Prieto VG, Khaleeq A, Kim S, Esmaeli B. Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa. Arch Otolaryngol Head Neck Surg. 2007;133:820–826. doi:10.1001/archotol.133.8.820
  • Cohen VM, Tsimpida M, Hungerford JL, Jan H, Cerio R, Moir G. Prospective study of sentinel lymph node biopsy for conjunctival melanoma. Br J Ophthalmol. 2013;97:1525–1529. doi:10.1136/bjophthalmol-2013-303671
  • Aziz HA, Gastman BR, Singh AD. Management of conjunctival melanoma: critical assessment of sentinel lymph node biopsy. Ocul Oncol Pathol. 2015;1:266–273. doi:10.1159/000381719
  • Wainstein AJ, Drummond-Lage AP, Kansaon MJ, et al. Sentinel lymph node biopsy for conjunctival malignant melanoma: surgical techniques. Clin Ophthalmol. 2014;9:1–6. doi:10.2147/OPTH.S71226
  • Rubinstein TJ, Perry JD, Korn JM, Costin BR, Gastman BR, Singh AD. Indocyanine green-guided sentinel lymph node biopsy for periocular tumors. Ophthalmic Plast Reconstr Surg. 2014;30:301–304. doi:10.1097/IOP.0000000000000096
  • Nijhawan N, Ross MI, Diba R, Ahmadi MA, Esmaeli B. Experience with sentinel lymph node biopsy for eyelid and conjunctival malignancies at a cancer center. Ophthalmic Plast Reconstr Surg. 2004;20:291–295.
  • Schwarz KA, Davison SP, Crane AE. Sentinel lymph node biopsy in the setting of conjunctival melanoma. Plast Reconstr Surg. 2008;121:212e–3e. doi:10.1097/01.prs.0000305377.95793.24
  • Baroody M, Holds JB, Kokoska MS, Boyd J. Conjunctival melanoma metastasis diagnosed by sentinel lymph node biopsy. Am J Ophthalmol. 2004;137:1147–1149. doi:10.1016/j.ajo.2004.01.014
  • Sherman DD, Gonnering RS, Wallow IH, et al. Identification of orbital lymphatics: enzyme histochemical light microscopic and electron microscopic studies. Ophthalmic Plast Reconstr Surg. 1993;9:153–169.
  • Echegoyen JC, Hirabayashi KE, Lin KY, Tao JP. Imaging of eyelid lymphatic drainage. Saudi J Ophthalmol. 2012;26:441–443. doi:10.1016/j.sjopt.2012.08.003
  • Maalouf TJ, Dolivet G, Angioi KS, Leroux A, Genin P, George JL. Sentinel lymph node biopsy in patients with conjunctival and eyelid cancers: experience in 17 patients. Ophthalmic Plast Reconstr Surg. 2012;28:30–34. doi:10.1097/IOP.0b013e31822fb44b
  • Chang JM, Kosiorek HE, Dueck AC, et al. Stratifying SLN incidence in intermediate thickness melanoma patients. Am J Surg. 2018;215:699–706. doi:10.1016/j.amjsurg.2017.12.009
  • Rubinstein TJ, Plesec TP, Singh AD. Sarcoid-like reaction in sentinel lymph node draining conjunctival melanoma. Ophthalmic Plast Reconstr Surg. 2015;31:e1–3. doi:10.1097/IOP.0000000000000018
  • Rubinstein TJ, Plesec TP, Singh AD. Desmoplastic melanoma of the eyelid and conjunctival melanoma in neurofibromatosis type 1: a clinical pathological correlation. Surv Ophthalmol. 2015;60:72–77. doi:10.1016/j.survophthal.2014.08.001
  • Motomura H, Sakamoto M, Maruyama Y, Harada T, Ishii M. Sentinel lymph node biopsy in conjunctival malignant melanoma at the lacrimal caruncle: a case report. Osaka City Med J. 2010;56:5–10.
  • Wilson MW, Fleming JC, Fleming RM, Haik BG. Sentinel node biopsy for orbital and ocular adnexal tumors. Ophthalmic Plast Reconstr Surg. 2001;17:338–344. discussion 344-5.
  • Vuthaluru S, Pushker N, Lokdarshi G, et al. Sentinel lymph node biopsy in malignant eyelid tumor: hybrid single photon emission computed tomography/computed tomography and dual dye technique. Am J Ophthalmol. 2013;156:43–49. doi:10.1016/j.ajo.2013.02.015
  • Savar A, Ross MI, Prieto VG, Ivan D, Kim S, Esmaeli B. Sentinel lymph node biopsy for ocular adnexal melanoma: experience in 30 patients. Ophthalmology. 2009;116:2217–2223. doi:10.1016/j.ophtha.2009.04.012
  • Klemen ND, Han G, Leong SP, et al. Completion lymphadenectomy for a positive sentinel node biopsy in melanoma patients is not associated with a survival benefit. J Surg Oncol. 2019. [ Epub ahead of print]. doi:10.1002/jso.25444